INDP Indaptus Therapeutics: Business Value

Indaptus Corp - graphic logo of issuer INDP

This daily price chart for Indaptus Therapeutics (INDP) demonstrates an Enterprise Value of 496.03. Indaptus Therapeutics (INDP) strictly adheres to environmental regulations regarding bio-waste disposal within its research frameworks. The efficiency of biomaterial supplies is ensured through temperature control and an extensive network of laboratories. Furthermore, Indaptus Therapeutics (INDP) is developing scientific partnerships with oncology centers to create advanced methods for combating resistant tumors.

INDP (indaptusrx.com) Total Company Value history from 11/23/2025 to 10/28/2026
Original product of Indaptus Therapeutics

The enterprise value dynamics reflect the financial capacity of Indaptus Therapeutics (INDP) within the context of developing innovative bacterial immunotherapies to combat solid tumors. This indicator aggregates market capitalization and total liabilities minus liquid assets, determining the actual acquisition price of the business and allowing investors to assess asset quality through the lens of net debt.

Competitor analysis for Indaptus Therapeutics

Business Value argenx N.V. ARGX|BioNTech Group (BNTX) - Enterprise Value|ABVX: Business Value|Total Company Value ADMA Biologics (ADMA)|PTGX (protagonist-inc.com) - Full Business Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Total Enterprise Value Astria Therapeutics Inc ATXS|Enterprise Value ENGN (enGene Bio)|RAPT: Company Buyout Price|Total Company Value aerovatetx.com|aclaristx.com (ACRS) - Business Value|Enterprise Value Kyverna Therapeutics, Inc. (KYTX)|Business Value Tiziana Life Sciences Ltd.|Enterprise Value CABA|Enterprise Value VTYX (Ventyx Biosciences, Inc)|Theratechnologies Inc. (THTX) - Total Company Value|AVTX - Full Business Value|Real Price to Acquire Entire Company Eledon Pharmaceuticals, Inc. ELDN|Agenus, Inc. (AGEN) - Aggregate Business Value|CLYM: Real Price to Acquire Entire Company|ZURA (Zura Bio Ltd) - Enterprise Value|ATYR: Total Company Value|Company Buyout Price Adagene Corp (ADAG)|ImageneBio Inc (IMA) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash shattucklabs.com STTK|Real Price to Acquire Entire Company Equillium (EQ)|Aggregate Business Value Connect Biopharma Holdings CNTB|Enterprise Value Immunic Inc (IMUX)|ATRA - Value Adjusted for Debt and Cash|Enterprise Value IFRX|XFOR (X4 Pharmaceuticals Inc.) - Total Enterprise Value|ACET - Total Company Value|Value Adjusted for Debt and Cash Celularity Corp|Enterprise Value INMB|Enterprise Value BRNS (barinthusbio.com)|Kezar Life Sciences, Inc. (KZR) - Total Company Value|Full Business Value SAB Biotherapeutics Inc. SABS|AKTX (Akari Therapeutics plc) - Enterprise Value|Enlivex Therapeutics (ENLV) - Total Enterprise Value|QTTB: Real Price to Acquire Entire Company|Enterprise Value geovax.com|Edesa Biotech (EDSA) - Real Price to Acquire Entire Company|Aggregate Business Value iBio Inc|CARM (Carisma Therapeutics) - Enterprise Value|Company Buyout Price XTL Bio (XTLB)|Bolt Biotherapeutics, Inc. - Enterprise Value|HCW Biologics, Inc. - Real Price to Acquire Entire Company|Total Company Value APVO (Aptevo)|AIM - Company Buyout Price|aditxt.com - Enterprise Value|GRI (GRI Bio Corporation) - Company Buyout Price|Total Company Value XORTX Therapeutics Inc. (XRTX)|Business Value reshapelifesciences.com|Enterprise Value Revelation Biosciences, Inc. REVB|Business Value SCNI (Scinai Immunotherapeutics Ltd)|CalciMedica (CALI) - Total Company Value|Affimed NV - Full Business Value|Total Company Value Allakos Therapeutics|HOOK - Full Business Value|Enterprise Value igmbio.com IGMS|iTeos Therapeutics Inc (ITOS) - Value Adjusted for Debt and Cash|OCEA (Ocean Bio) - Enterprise Value|Enterprise Value TCBP|Third Harmonic Bio (THRD) - Total Company Value